These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6275335)

  • 1. Lung surfactant in an era of replacement therapy.
    Notter RH; Shapiro DL
    Pediatrics; 1981 Dec; 68(6):781-9. PubMed ID: 6275335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical behavior of lung surfactant: implications for respiratory physiology and pathophysiology.
    Notter RH
    Semin Perinatol; 1988 Jul; 12(3):180-212. PubMed ID: 3041603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung surfactants for replacement therapy: biochemical, biophysical, and clinical aspects.
    Notter RH; Shapiro DL
    Clin Perinatol; 1987 Sep; 14(3):433-79. PubMed ID: 3311535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of exogenous surfactant replacement therapy on lung function.
    Yüksel B; Greenough A
    Turk J Pediatr; 1993; 35(1):53-7. PubMed ID: 8236518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
    Jobe A
    Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The era of pulmonary surfactant from Laplace to nowadays.
    Parmigiani S; Solari E
    Acta Biomed; 2003 Aug; 74(2):69-75. PubMed ID: 14509914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous surfactant therapy in newborns.
    Rodriguez RJ; Martin RJ
    Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome].
    Silberg IE; Grønn M
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1456-8. PubMed ID: 9198922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary surfactant: functions, abnormalities and therapeutic options.
    Frerking I; Günther A; Seeger W; Pison U
    Intensive Care Med; 2001 Nov; 27(11):1699-717. PubMed ID: 11810113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary surfactant.
    Dobbs LG
    Annu Rev Med; 1989; 40():431-46. PubMed ID: 2658759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung development and the pulmonary surfactant system: hormonal ifluences.
    Hitchcock KR
    Anat Rec; 1980 Sep; 198(1):13-34. PubMed ID: 6257147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited disorders of neonatal lung diseases.
    Yurdakök M
    Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biochemistry of fetal lung development.
    Kresch MJ; Gross I
    Clin Perinatol; 1987 Sep; 14(3):481-507. PubMed ID: 3311536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies regarding surfactant replacement therapy.
    Shapiro DL; Notter RH
    Clin Perinatol; 1988 Dec; 15(4):891-902. PubMed ID: 3061705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous surfactant therapy: newer developments.
    Lacaze-Masmonteil T
    Semin Neonatol; 2003 Dec; 8(6):433-40. PubMed ID: 15001115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of bovine surfactant for infants with respiratory distress syndrome.
    Taeusch HW; Keough KM; Williams M; Slavin R; Steele E; Lee AS; Phelps D; Kariel N; Floros J; Avery ME
    Pediatrics; 1986 Apr; 77(4):572-81. PubMed ID: 3634296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
    Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of surfactant replacement trials.
    Suresh GK; Soll RF
    J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.